drugset
drugset / Trial / NCT04143750

The Mass Balance and Biotransformation of [14C] Vicagrel in Healthy Man

NCT04143750 ↗

Phase 1 Completed 6 enrolled Jiangsu vcare pharmaceutical technology co., LTD
NaSingle-groupOpen-labelOther

Summary

This study was designed to evaluate the mass balance and biotransformation after single-dose of \[14C\]Vicagrel orally in Chinese healthy male volunteers, revealing the overall pharmacokinetic characteristics of vicagrel in humans, and providing a reference for the rational administration.

Timeline

Start
2019-11-11
Primary completion
2019-12-29
Completion
2020-01-14

Drugs

EvaluationDrugModalityDoseRoute
Subject SUMECIGREL Small molecule 20 mg Oral

Indications

No indication recorded.